Trichomoniasis: Clinical Trials

2 trials for Trichomoniasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Trichomoniasis: new trials by email Literature Review of Trichomoniasis trials Research Report on Trichomoniasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safer Sex Program for Young African-American Men
Intervention - Gonorrhea, Chlamydia
Phase 2CompletedRichard Crosby6202012-09-012019-02-21
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
Neo-Penotran® Forte (active ingredient Metronidazole & Miconazole Nitrate), Placebo - Bacterial Vaginosis, Candidiasis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2342011-04-012014-10-06

Narrower conditions

Trichomonas Infections (2)  ·  Candidiasis (1)  ·  Candidiasis, Vulvovaginal (1)  ·  Chlamydia Infections (1)  ·  Gonorrhea (1)  ·  HIV Infections (1)  ·  Syphilis (1)  ·  Vaginosis, Bacterial (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Genital Diseases (2)  ·  Infections (2)  ·  Parasitic Diseases (2)  ·  Protozoan Infections (2)  ·  Urogenital Diseases (2)  ·  Blood-Borne Infections (1)  ·  Chlamydiaceae Infections (1)  ·  Communicable Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases, Female (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Immune System Diseases (1)

Interventions

Methods (1)  ·  Miconazole (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Richard Crosby (1)

Countries

United States (2)  ·  Kenya (1)

Top investigators

Leandro A Mena, MD (1)  ·  Richard A Crosby, PhD (1)

NIH funding

R01MH092226 (1)